Literature DB >> 20335430

Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Masae Iwai1, Hiromu Yoshida, Mayumi Obara, Eiji Horimoto, Kazuya Nakamura, Takenori Takizawa, Takeshi Kurata, Mineyuki Mizuguchi, Tohru Daikoku, Kimiyasu Shiraki.   

Abstract

To confirm the magnitude of an echovirus type 13 (E13) outbreak in 2002 and to evaluate whether genetic and antigenic changes in E13 influenced the occurrence of the outbreak, we measured titers of neutralizing (NT) antibody against the Toyama, 2002-240-SF, and prototype Del Carmen E13 strains among inhabitants of Toyama before and after 2002. The rate of positivity for NT antibodies against both 2002-240-SF and Del Carmen in 2003 made a remarkable upturn in children 0 to 14 years old, compared to that in 2000. Titers of NT antibody against strain 2002-240-SF of inhabitants were slightly higher than those against Del Carmen, whereas anti-E13 rabbit serum raised against either strain Del Carmen or 2002-240-SF showed almost the same titer of NT antibody against both strains. These data indicate that the antigenic properties of the strains may be slightly different. Differences in amino acids between strains 2002-240-SF and Del Carmen in the VP4, VP2, VP3, and VP1 regions may affect both antigenic and receptor binding properties, even though they do not seem to be significant enough to escape widespread immunity. One of the factors of the outbreak was thought to be the increase in susceptibility in the young generation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20335430      PMCID: PMC2863381          DOI: 10.1128/CVI.00239-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  28 in total

1.  Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Authors:  Amanda D Stuart; Thomas A McKee; Pamela A Williams; Chris Harley; Shuo Shen; David I Stuart; T David K Brown; Susan M Lea
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Identification of enteroviruses by using monoclonal antibodies against a putative common epitope.

Authors:  Soo-Youn Shin; Ki-Soon Kim; Yoon-Sung Lee; Yoon-Seok Chung; Kwi-Sung Park; Doo-Sung Cheon; Byoung-Kuk Na; Yoonsung Kang; Hyang-Min Cheong; Youngjoon Moon; Jee-Hye Choi; Hang-Eui Cho; Na-Young Min; Jin-Sook Son; Young-Hoon Park; Youngmee Jee; Jae-Deuk Yoon; Chul-Yong Song; Kwang-Ho Lee
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

3.  Re-emergence of echovirus type 13 infections in 2002 in Yamagata, Japan.

Authors:  Katsumi Mizuta; Chieko Abiko; Toshio Murata; Tsutomu Itagaki; Noriko Katsushima; Tomoharu Akiba; Michiyo Sakamoto; Katsumi Ootani; Shoko Murayama
Journal:  J Infect       Date:  2003-10       Impact factor: 6.072

4.  Echovirus type 13--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-09-14       Impact factor: 17.586

5.  Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007.

Authors:  Masae Iwai; Akio Masaki; Sumiyo Hasegawa; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Yuichi Tanaka; Kyoko Endo; Keiko Tanaka; Junko Ueda; Kimiyasu Shiraki; Takeshi Kurata; Takenori Takizawa
Journal:  Jpn J Infect Dis       Date:  2009-07       Impact factor: 1.362

6.  [Adult cases of viral meningitis caused by echovirus type 13].

Authors:  Hiromi Tsutsui; Tadanori Hamano; Miho Toho; Masako Nakamura; Koji Hayashi; Osamu Yamamura; Hiroto Nakagawa; Jiro Fujiyama; Makoto Yoneda; Masaru Kuriyama
Journal:  Rinsho Shinkeigaku       Date:  2003-06

7.  Antigenic sites of coxsackie A9 virus inducing neutralizing monoclonal antibodies protective in mice.

Authors:  Gabriele Buttinelli; Valentina Donati; Franco M Ruggeri; Paivi Joki-Korpela; Timo Hyypia; Lucia Fiore
Journal:  Virology       Date:  2003-07-20       Impact factor: 3.616

8.  Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000.

Authors:  Christine Archimbaud; Jean-Luc Bailly; Martine Chambon; Olivier Tournilhac; Philippe Travade; Hélène Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Aseptic meningitis in Germany associated with echovirus type 13.

Authors:  S Diedrich; E Schreier
Journal:  BMC Infect Dis       Date:  2001-09-14       Impact factor: 3.090

10.  Molecular analysis of echovirus 13 isolates and aseptic meningitis, Spain.

Authors:  Ana Avellón; Inmaculada Casas; Gloria Trallero; Carmen Pérez; Antonio Tenorio; Gustavo Palacios
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

View more
  3 in total

1.  Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan.

Authors:  Tomofumi Nakamura; Mitsuhiro Hamasaki; Hideaki Yoshitomi; Tetsuya Ishibashi; Chiharu Yoshiyama; Eriko Maeda; Nobuyuki Sera; Hiromu Yoshida
Journal:  Appl Environ Microbiol       Date:  2015-01-02       Impact factor: 4.792

Review 2.  Recombination among human non-polio enteroviruses: implications for epidemiology and evolution.

Authors:  Zaharoula Kyriakopoulou; Vaia Pliaka; Grigoris D Amoutzias; Panayotis Markoulatos
Journal:  Virus Genes       Date:  2014-12-24       Impact factor: 2.332

3.  Genetic characterization of a novel recombinant echovirus 30 strain causing a regional epidemic of aseptic meningitis in Hokkaido, Japan, 2017.

Authors:  Masahiro Miyoshi; Akiko Goto; Rika Komagome; Hiroki Yamaguchi; Yuji Maruo; Masanori Nakanishi; Setsuko Ishida; Hideki Nagano; Takahisa Sugisawa; Motohiko Okano
Journal:  Arch Virol       Date:  2019-12-11       Impact factor: 2.574

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.